BIG PHARMA WATCH: DRUG MAKER PRICES CHEMO TREATMENT TEN TIMES ABOVE THE MARKET AS PATIENTS FACE SHORTAGES
Areva Pharmaceuticals Price-Gouges Cancer Patients Who Rely on Older Oncology… Read More
Areva Pharmaceuticals Price-Gouges Cancer Patients Who Rely on Older Oncology… Read More
The Problem with Insulin Affordability is the Price, Driven by “Shadow… Read More
HHS Reports Demonstrate Cost of Big Pharma Egregious Pricing Practices and… Read More
Biogen Agrees to Settle Case Over Illegally Paying Doctors to Push Brand Name… Read More
Novartis Exec Calls Policy to Keep Price Hikes Below Inflation… Read More
I-MAK Analysis Finds Anti-Competitive Practices That Extend Exclusivity Will… Read More
Researchers Say Brand Name Drug Companies’ So-Called Patient Assistance… Read More
Analysis Finds Brand Name Manufacturers Bringing New Drugs to Market with… Read More
Committee Report Shows How Brand Name Drug Company Further Juiced Profits on… Read More
Nearly Half of All New Brand Name Drugs Cost More Than $150,000 Per Year In… Read More
Brand Name Drug Companies Posted Massive Profit Growth and Invested Heavily in… Read More
Brand Name Drug Companies Four Times as Likely to Reformulate Blockbuster… Read More